Interventional Pulmonology Market

Global Market Study on Interventional Pulmonology: Rising Prevalence of Respiratory Diseases Augment Market Expansion

Interventional Pulmonology Market Segmented By Electromagnetic Navigation Bronchoscopy, IP Diagnostic Devices, IP Therapeutic Devices, Product in Asthma, Lung Cancer, COPD, Foreign Body Extraction, Tracheal and Bronchial Stenosis Indication

  • March-2021
  • PMRREP12544
  • 270 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

4. Key Success Factors

    4.1. Value Chain Analysis 

    4.2. Regulatory Scenario

    4.3. Tracheal and Bronchial Stenosis Procedures, By Key Regions

    4.4. Key Interventional Pulmonology Procedure Statistics, By key Region 

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Spending  

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing prevalence of Respiratory Diseases 

        5.2.2. Cost of Treatment

        5.2.3. Government Funding to Support Healthcare

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Trends

        5.3.4. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 Economic analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue by Product

        6.4.2. Revenue by Indication

        6.4.3. Revenue by End User 

        6.4.4. Revenue By Country

    6.5. Industrial Outlook

    6.6. Economic Impact

    6.7. COVID19 Crisis Analysis Probable Future Impact

7. Global Interventional Pulmonology Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Volume (Units) Analysis, 2016-2020

    7.2. Current and Future Market Volume (Units) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Interventional Pulmonology Market- Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

   8.3. Global Average Pricing Analysis Benchmark

9. Global Interventional Pulmonology Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) By Product, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021-2031

        10.3.1. Electromagnetic Navigation Bronchoscopy (ENB)

        10.3.2. IP Diagnostic Devices

            10.3.2.1. Bronchoscopes

                10.3.2.1.1. Flexible Bronchoscope

                10.3.2.1.2. Rigid bronchoscope

            10.3.2.2. EBUS

            10.3.2.3. Aspiration Needles

            10.3.2.4. Biopsy Foreceps

            10.3.2.5. Pleuroscopes

                10.3.2.5.1. Semi-flexible Pleuroscopes

                10.3.2.5.2. Rigid Pleuroscopes

            10.3.2.6. Others

        10.3.3. IP therapeutic devices

            10.3.3.1. Airway Stents

            10.3.3.2. Endobronchial Ablation Systems

            10.3.3.3. Pleural drainage catheters

            10.3.3.4. Endobronchial Valves

    10.4. Market Attractiveness Analysis By Product

11. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) By Availability, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2021-2031

        11.3.1. Asthma

        11.3.2. Lung Cancer

        11.3.3. COPD

        11.3.4. Foreign Body Extraction

        11.3.5. Tracheal and Bronchial Stenosis

    11.4. Market Attractiveness Analysis By Indication

12. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By End User 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) By End User , 2016-2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2021-2031

        12.3.1. Hospitals

        12.3.2. Pulmonology Clinics

        12.3.3. Ambulatory Surgical Centers

        12.3.4. Diagnostic Centers    

    12.4. Market Attractiveness Analysis By End User 

13. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2020

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021-2031

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By End User 

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018

    15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021-2031

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By End User 

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2021-2031

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.1. By Product

        16.3.2. By Indication

        16.3.3. By End User  

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2021-2031

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.1. By Product

        17.3.2. By Indication

        17.3.3. By End User 

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.1. By Product

        18.3.2. By Indication

        18.3.3. By End User 

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2016-2020

    19.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.1. By  Product

        19.3.2. By Indication

        19.3.3. By End User 

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    20.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031

        20.3.1.  By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Product

        20.3.3. By Indication

        20.3.4. By End User 

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key Countries Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

    21.1. U.S. Interventional Pulmonology Market Analysis

        21.1.1. By Product

        21.1.1. By Indication

        21.1.2. By End User 

    21.2. Canada Interventional Pulmonology Market Analysis

        21.2.1. By Product

        21.2.1. By Indication

        21.2.2. By End User 

    21.3. Brazil Interventional Pulmonology Market Analysis

        21.3.1. By Product

        21.3.1. By Indication

        21.3.2. By End User 

    21.4. Mexico Interventional Pulmonology Market Analysis

        21.4.1. By Product

        21.4.1. By Indication

        21.4.2. By End User 

    21.5. Argentina Interventional Pulmonology Market Analysis

        21.5.1. By Product

        21.5.1. By Indication

        21.5.2. By End User 

    21.6. U.K. Interventional Pulmonology Market Analysis

        21.6.1. By Product

        21.6.1. By Indication

        21.6.2. By End User 

    21.7. Germany Interventional Pulmonology Market Analysis

        21.7.1. By Product

        21.7.1. By Indication

        21.7.2. By End User 

    21.8. France Interventional Pulmonology Market Analysis

        21.8.1. By Product

        21.8.1. By Indication

        21.8.2. By End User 

    21.9. Italy Interventional Pulmonology Market Analysis

        21.9.1. By Product

        21.9.1. By  Indication

        21.9.2. By End User 

    21.10. Spain Interventional Pulmonology Market Analysis

        21.10.1. By Product

        21.10.1. By Indication

        21.10.2. By End User   

    21.11. BENELUX Interventional Pulmonology Market Analysis

        21.11.1. By Product

        21.11.1. By Indication

        21.11.2. By End User 

    21.12. Russia Interventional Pulmonology Market Analysis

        21.12.1. By Product

        21.12.1. By Indication

        21.12.2. By End User 

    21.13. Japan Interventional Pulmonology Market Analysis

        21.13.1. By Product

        21.13.1. By Indication

        21.13.2. By End User 

    21.14. China Interventional Pulmonology Market Analysis

        21.14.1. By Product

        21.14.1. By Indication

        21.14.2. By End User 

    21.15. South Korea Interventional Pulmonology Market Analysis

        21.15.1. By Product

        21.15.1. By Indication

        21.15.2. By End User 

    21.16. India Interventional Pulmonology Market Analysis

        21.16.1. By Product

        21.16.1. By Indication

        21.16.2. By End User 

    21.17. ASEAN Interventional Pulmonology Market Analysis

        21.17.1. By Product

        21.17.1. By Indication

        21.17.2. By End User 

    21.18. Australia Interventional Pulmonology Market Analysis

        21.18.1. By Product

        21.18.1. By Indication

        21.18.2. By End User 

    21.19. New Zealand Interventional Pulmonology Market Analysis

        21.19.1. By Product

        21.19.1. By Indication

        21.19.2. By End User 

    21.20. GCC Countries Interventional Pulmonology Market Analysis

        21.20.1. By Product

        21.20.1. By Indication

        21.20.2. By End User 

    21.21. Turkey Interventional Pulmonology Market Analysis

        21.21.1. By Product

        21.21.1. By Indication

        21.21.2. By End User 

    21.22. South Africa Interventional Pulmonology Market Analysis

        21.22.1. By Product

        21.22.1. By Indication

        21.22.2. By End User 

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies 

    22.2. Market Concentration

    22.3. Market Share Analysis of Top Players

    22.4. Market Presence Analysis

            22.4.1.1. Regional footprint of Players

            22.4.1.2. Method foot print by Players

            22.4.1.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Deep Dive 

        23.2.1. Medtronic Plc  

            23.2.1.1. Overview

            23.2.1.2. Product Portfolio

            23.2.1.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.1.4. Sales Footprint

            23.2.1.5. Strategy Overview

                23.2.1.5.1. Marketing Strategy

                23.2.1.5.2. Product Strategy

                23.2.1.5.3. Channel Strategy 

        23.2.2. Boston Scientific Corporation  

            23.2.2.1. Overview

            23.2.2.2. Product Portfolio

            23.2.2.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.2.4. Sales Footprint

            23.2.2.5. Strategy Overview

                23.2.2.5.1. Marketing Strategy

                23.2.2.5.2. Product Strategy

                23.2.2.5.3. Channel Strategy 

        23.2.3. Olympus Corporation 

            23.2.3.1. Overview

            23.2.3.2. Product Portfolio

            23.2.3.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.3.4. Sales Footprint

            23.2.3.5. Strategy Overview

                23.2.3.5.1. Marketing Strategy

                23.2.3.5.2. Product Strategy

                23.2.3.5.3. Channel Strategy 

        23.2.4. FUJIFILM Corporation 

            23.2.4.1. Overview

            23.2.4.2. Product Portfolio

            23.2.4.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.4.4. Sales Footprint

            23.2.4.5. Strategy Overview

                23.2.4.5.1. Marketing Strategy

                23.2.4.5.2. Product Strategy

                23.2.4.5.3. Channel Strategy 

        23.2.5. Becton, Dickinson and Company

            23.2.5.1. Overview

            23.2.5.2. Product Portfolio

            23.2.5.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.5.4. Sales Footprint

            23.2.5.5. Strategy Overview

                23.2.5.5.1. Marketing Strategy

                23.2.5.5.2. Product Strategy

                23.2.5.5.3. Channel Strategy 

        23.2.6. Smiths Group Plc 

            23.2.6.1. Overview

            23.2.6.2. Product Portfolio

            23.2.6.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.6.4. Sales Footprint

            23.2.6.5. Strategy Overview

                23.2.6.5.1. Marketing Strategy

                23.2.6.5.2. Product Strategy

                23.2.6.5.3. Channel Strategy 

        23.2.7. Cook Medical

            23.2.7.1. Overview

            23.2.7.2. Product Portfolio

            23.2.7.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.7.4. Sales Footprint

            23.2.7.5. Strategy Overview

                23.2.7.5.1. Marketing Strategy

                23.2.7.5.2. Product Strategy

                23.2.7.5.3. Channel Strategy 

        23.2.8. Vygon

            23.2.8.1. Overview

            23.2.8.2. Product Portfolio

            23.2.8.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.8.4. Sales Footprint

            23.2.8.5. Strategy Overview

                23.2.8.5.1. Marketing Strategy

                23.2.8.5.2. Product Strategy

                23.2.8.5.3. Channel Strategy 

        23.2.9. Clarus Medical LLC

            23.2.9.1. Overview

            23.2.9.2. Product Portfolio

            23.2.9.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.9.4. Sales Footprint

            23.2.9.5. Strategy Overview

                23.2.9.5.1. Marketing Strategy

                23.2.9.5.2. Product Strategy

                23.2.9.5.3. Channel Strategy 

        23.2.10. Huger Medical Instrument Co. Ltd

            23.2.10.1. Overview

            23.2.10.2. Product Portfolio

            23.2.10.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.10.4. Sales Footprint

            23.2.10.5. Strategy Overview

                23.2.10.5.1. Marketing Strategy

                23.2.10.5.2. Product Strategy

                23.2.10.5.3. Channel Strategy 

        23.2.11. Taewoong Medical Co. Ltd.

            23.2.11.1. Overview

            23.2.11.2. Product Portfolio

            23.2.11.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.11.4. Sales Footprint

            23.2.11.5. Strategy Overview

                23.2.11.5.1. Marketing Strategy

                23.2.11.5.2. Product Strategy

                23.2.11.5.3. Channel Strategy 

        23.2.12. Shanghai AoHua Photoelectricity Endoscope Co., Ltd

            23.2.12.1. Overview

            23.2.12.2. Product Portfolio

            23.2.12.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.12.4. Sales Footprint

            23.2.12.5. Strategy Overview

                23.2.12.5.1. Marketing Strategy

                23.2.12.5.2. Product Strategy

                23.2.12.5.3. Channel Strategy 

        23.2.13. Karl Storz

            23.2.13.1. Overview

            23.2.13.2. Product Portfolio

            23.2.13.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.13.4. Sales Footprint

            23.2.13.5. Strategy Overview

                23.2.13.5.1. Marketing Strategy

                23.2.13.5.2. Product Strategy

                23.2.13.5.3. Channel Strategy 

        23.2.14. Richard Wolf Corporation

            23.2.14.1. Overview

            23.2.14.2. Product Portfolio

            23.2.14.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.14.4. Sales Footprint

            23.2.14.5. Strategy Overview

                23.2.14.5.1. Marketing Strategy

                23.2.14.5.2. Product Strategy

                23.2.14.5.3. Channel Strategy 

        23.2.15. PENTAX Medical

            23.2.15.1. Overview

            23.2.15.2. Product Portfolio

            23.2.15.3. Profitability by Market Segments (Product/Channel/Region)

            23.2.15.4. Sales Footprint

            23.2.15.5. Strategy Overview

                23.2.15.5.1. Marketing Strategy

                23.2.15.5.2. Product Strategy

                23.2.15.5.3. Channel Strategy 

24. Assumptions and Acronyms Used

25. Research Methodology

Find Out More about the Report Coverage

List of Tables

Table 01: Global Interventional Pulmonology Market Volume (in '000 Unit) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 02: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 03: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 04: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 05: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 06: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 07: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 08: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 09: U.S. Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 10: U.S. Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 11: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 12: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 13: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 14: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 15: China Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 16: China Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 17: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 18: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 19: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 20: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 21: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 22: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 23: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 24: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 25: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 26: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)

Table 27: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 28: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product(1/2)

Table 29: ROW Interventional Pulmonology Market Volume (in ‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)

Table 30: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication

Table 31: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 01: Global Interventional Pulmonology Market Share, By Product (2020)

Figure 02: Global Interventional Pulmonology Market Share, By Indication (2020)

Figure 03: Global Interventional Pulmonology Market Share, By End User (2020)

Figure 04: Global Interventional Pulmonology Market Share, By Region (2020)

Figure 05: Global Interventional Pulmonology Market Volume (in '000 Unit) Analysis, 2016–2020

Figure 06: Global Interventional Pulmonology Market Volume (in '000 Unit) & Y-o-Y Growth (%) Analysis, 2021-2031

Figure 07: Global Interventional Pulmonology(ENB, EBUS and Endobronchial Ablation Systems) ,Price Difference (US$) By Region, 2020

Figure 08: Global Interventional Pulmonology(ENB, EBUS and Endobronchial Ablation Systems) ,Price Difference (US$) By Region, 2031

Figure 09: Global Interventional Pulmonology Market Attractiveness Analysis 2021-2031, by Indication

Figure 10: Global Interventional Pulmonology(Semi-flexible Pleuroscopes and Rigid Pleuroscopes) , Price Difference (US$) By Region, 2031

Figure 11: Global Interventional Pulmonology(Flexible Bronchoscope, Rigid bronchoscope) , Price Difference (US$) By Region, 2020

Figure 12: Global Interventional Pulmonology(Flexible Bronchoscope, Rigid bronchoscope) , Price Difference (US$) By Region, 2031

Figure 13: Global Interventional Pulmonology(Aspiration Needles, Biopsy Forceps, Others) ,Price Difference (US$) By Region, 2020

Figure 14: Global Interventional Pulmonology(Aspiration Needles, Biopsy Forceps, Others) , Price Difference (US$) By Region, 2031

Figure 15: Global Interventional Pulmonology(Airway Stents, Pleural drainage catheters, Endobronchial Valves) , Price Difference (US$) By Region, 2020

Figure 16: Global Interventional Pulmonology(Airway Stents, Pleural drainage catheters, Endobronchial Valves) , Price Difference (US$) By Region, 2031

Figure 17: Global Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016–2020

Figure 18: Global Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2031

Figure 19: Global Interventional Pulmonology Market Absolute $ Opportunity Analysis, 2021-2031

Figure 20: Global Interventional Pulmonology Market Analysis by Product–2021 & 2031

Figure 21: Global Interventional Pulmonology Market Y-o-Y Growth Projections by Product, 2021 – 2031

Figure 22: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product 

Figure 23: Global Interventional Pulmonology Market Analysis by Indication –2021 & 2031

Figure 24: Global Interventional Pulmonology Market Y-o-Y Growth Projections by Indication , 2021 – 2031

Figure 25: Global Interventional Pulmonology Market Analysis by End User–2021 & 2031

Figure 26: Global Interventional Pulmonology Market Y-o-Y Growth Projections by End User, 2021 – 2031

Figure 27: Global Interventional Pulmonology Market Attractiveness Analysis 2021-2031, by End User

Figure 28: Global Interventional Pulmonology Market Analysis by Region–2021 & 2031

Figure 29: Global Interventional Pulmonology Market Y-o-Y Growth Projections by Region, 2021 – 2031

Figure 30: Global Interventional Pulmonology Market Attractiveness Analysis 2021-2031, By Region

Figure 31: U.S. Interventional Pulmonology Market Share, By Product, 2021 (E)

Figure 32: U.S. Interventional Pulmonology Market Share, By Indication, 2021 (E)

Figure 33: U.S. Interventional Pulmonology Market Share, By End User, 2021 (E)

Figure 34: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020

Figure 35: U.S. Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 36: U.S. Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031

Figure 37: U.S. Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031

Figure 38: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Figure 39: China Interventional Pulmonology Market Share, By Product, 2021 (E)

Figure 40: China Interventional Pulmonology Market Share, By Indication, 2021 (E)

Figure 41: China Interventional Pulmonology Market Share, By End User, 2021 (E)

Figure 42: China Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020

Figure 43: China Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 44: China Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031

Figure 45: China Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031

Figure 46: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Figure 47: Europe Interventional Pulmonology Market Share, By Product, 2021 (E)

Figure 48: Europe Interventional Pulmonology Market Share, By Indication, 2021 (E)

Figure 49: Europe Interventional Pulmonology Market Share, By End User, 2021 (E)

Figure 50: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020

Figure 51: Europe Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 52: Europe Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031

Figure 53: Europe Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031

Figure 54: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Figure 55: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country

Figure 56: ROW Interventional Pulmonology Market Share, By Product, 2021 (E)

Figure 57: ROW Interventional Pulmonology Market Share, By Indication, 2021 (E)

Figure 58: ROW Interventional Pulmonology Market Share, By End User, 2021 (E)

Figure 59: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020

Figure 60: ROW Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 61: ROW Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031

Figure 62: ROW Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031

Figure 63: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Figure 64: Germany Market Value Proportion Analysis

Figure 65: Germany Interventional Pulmonology Market Share, By Product, 2021 & 2031

Figure 66: Germany Interventional Pulmonology Market Share, By Indication, 2021 & 2031

Figure 67: Germany Interventional Pulmonology Market Share, By End User, 2021 & 2031

Figure 68: U.K. Market Value Proportion Analysis

Figure 69: U.K. Interventional Pulmonology Market Share, By Product, 2021 & 2031

Figure 70: U.K. Interventional Pulmonology Market Share, By Indication, 2021 & 2031

Figure 71: U.K. Interventional Pulmonology Market Share, By End User, 2021 & 2031

Figure 72: France Market Value Proportion Analysis

Figure 73: France Interventional Pulmonology Market Share, By Product, 2021 & 2031

Figure 74: France Interventional Pulmonology Market Share, By Indication, 2021 & 2031

Figure 75: France Interventional Pulmonology Market Share, By End User, 2021 & 2031

Figure 76: Italy Market Value Proportion Analysis

Figure 77: Italy Interventional Pulmonology Market Share, By Product, 2021 & 2031

Figure 78: Italy Interventional Pulmonology Market Share, By Indication, 2021 & 2031

Figure 79: Italy Interventional Pulmonology Market Share, By End User, 2021 & 2031

Figure 80: Spain Market Value Proportion Analysis

Figure 81: Spain Interventional Pulmonology Market Share, By Product, 2021 & 2031

Figure 82: Spain Interventional Pulmonology Market Share, By Indication, 2021 & 2031

Figure 83: Spain Interventional Pulmonology Market Share, By End User, 2021 & 2031

Figure 84: Russia Market Value Proportion Analysis

Figure 85: Russia Interventional Pulmonology Market Share, By Product, 2021 & 2031

Figure 86: Russia Interventional Pulmonology Market Share, By Indication, 2021 & 2031

Figure 87: Russia Interventional Pulmonology Market Share, By End User, 2021 & 2031

Figure 88: BENELUX Market Value Proportion Analysis

Figure 89: BENELUX Interventional Pulmonology Market Share, By Product, 2021 & 2031

Figure 90: BENELUX Interventional Pulmonology Market Share, By Indication, 2021 & 2031

Figure 91: BENELUX Interventional Pulmonology Market Share, By End User, 2021 & 2031

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Interventional Pulmonology Market - Scope of Report

Persistence Market Research recently published a market study on the global market for interventional pulmonology. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the market structure. The market study presents exclusive information about how the interventional pulmonology market will grow during the forecast period of 2021-2031.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in Persistence Market Research’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the market during the forecast period.

The study is relevant for stakeholders in the interventional pulmonology market, including product manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in this space. Stakeholders in the interventional pulmonology market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in the study.

The study also includes statistics as well as facts related to the macro- as well as micro-economic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the market. Furthermore, small businesses and new entrants in the market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Segments of Market

Persistence Market Research’s study on the interventional pulmonology market offers information divided into four important segments — product, indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

  • Electromagnetic Navigation Bronchoscopy (ENB)
  • IP Diagnostic Devices
    • Bronchoscopes
      • Flexible Bronchoscope
      • Rigid bronchoscope
    • EBUS
    • Aspiration Needles
    • Biopsy Foreceps
    • Pleuroscopes
      • Semi-flexible Pleuroscopes
      • Rigid Pleuroscopes
    • Others
  • IP Therapeutic Devices
    • Airway Stents
    • Endobronchial Ablation Systems
    • Pleural Drainage Catheters
  • Endobronchial Valves

Indication

  • Asthma
  • Lung Cancer
  • COPD
  • Foreign Body Extraction
  • Tracheal and Bronchial Stenosis

End User

  • Hospitals
  • Pulmonology Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Region

  • Global
  • China
  • U.S.
  • Europe

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable regional markets for interventional pulmonology?
  • Which factors will induce a change in the demand for interventional pulmonology during the assessment period?
  • How will changing trends impact the interventional pulmonology market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • Which companies are leading the interventional pulmonology market?
  • What are the winning strategies of stakeholders in the market to upscale their position in this landscape?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the interventional pulmonology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the interventional pulmonology market, and makes Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.

Recommendations

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

2 Ethylhexanol Market

South Asia and Pacific and MEA, are estimated to witness a steady growth spurred by rapid economic development. These regions are estimated to hold a prominent share in the 2-ethylhexanol market during the forecast period..

Emea Dearomatic Solvents Market

Global De-aromatic solvents market is expected to register a CAGR of 5.0% over the forecast period (2016 – 2024), to reach valuation of US$ 556.0 Mn by 2024.

Bismuth Market

Global bismuth market is estimated reach around US$ 225 Mn in 2016 and is projected to expand at a moderate single-digit CAGR in terms of value from 2016-2024.

Our Clients

Our Clients